Ashley A. McCook‐Veal
Emory University(US)Cancer Research And Biostatistics(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Chronic Lymphocytic Leukemia Research, Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial(2023)74 cited
- → Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant(2022)40 cited
- → Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma(2024)13 cited
- → Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study(2022)10 cited
- → XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial(2025)9 cited
- → Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis(2024)8 cited
- → Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies(2022)7 cited
- → Impact of metformin on clinical outcomes in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors(2023)6 cited
- → Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study(2023)6 cited
- → BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer(2023)5 cited